Loading…
Loading…
CRL · NYSE · Healthcare
“A $7.7 billion enterprise losing $2.91 per share offers no margin of safety, regardless of its market position in laboratory services.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$7.73B
P/E Ratio
-53.57
Forward P/E
—
EPS
$-2.91
PEG Ratio
-1.63
Book Value
$63.85
Dividend Yield
—
Profit Margin
-3.59%
ROE
-4.56%
Use the interactive dividend analyzer with pre-loaded data for Charles River Laboratories International Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for CRL: